Search Browse Earnings

INTERPACE BIOSCIENCES, INC. — SlamSEC

INTERPACE BIOSCIENCES, INC.

OTC:IDXG

Surgical & Medical Instruments & Apparatus·PARSIPPANY, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$9.7M

-69.7% YoY

FY 2024

Adj. EBITDA

$1.9M

19.3% margin

FY 2024

Net Income

$514,000

5.3% margin

FY 2024

EPS (Diluted)

$0.12

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$5.6M

FY 2024

Total Debt

$13.0M

FY 2017

Net Debt

$7.4M

FY 2017

Enterprise Value

—

Debt / EBITDA

4.0x

FY 2024

EV / EBITDA

—

Employees

—

CFO

Mccarthy Christopher